Leash Bio
- Biotech or pharma, therapeutic R&D
- Other products or services
- Other R&D services
We're developing a proprietary, bespoke-for-ML dataset of small molecule and protein interactions that will unlock the ability of ML to identify novel hits for any protein target in silico.
Current ML approaches like AF3, Boltz-1 excel at predicting protein structure from sequence, and predicting the exact binding position of known small molecule compounds. But, the field still struggles to predict novel binders for any protein target, or affinity of binding because no sufficiently diverse and broad "PDB of medicinal chemistry"exists. We're building it and building the ML tools to do fully generative small molecule drug design to unlock faster, cheaper and more streamlined small molecule drug discovery.
We're actively seeking partners who share our vision in pushing ML beyond structure prediction. We're interested in fundraising as well as partnering our data/capabilities, and a few early stage programs.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}